Report Highlights
- The total market for drugs and cosmetics for aging boomers, as defined in this study, will reach an estimated $28.5 billion in sales in 2001.
- This market is expected to grow to $41.94 billion in 2006 at an average annual rate (AAGR) of 8%.
- The market with the highest projected AAGR (16.5%) is hormone replacement therapy. The numbers of those seeking relief from menopausal symptoms is steadily increasing.
- Other rapidly growing market segments are arthritis therapies, vision-related products, urinary incontinence products, skin care products and periodontal disease therapies.
- Boomers will be the best educated seniors in history and are expected to enjoy better health later in life as a result of better self-help and preventative activities.
INTRODUCTION
STUDY GOAL AND OBJECTIVES
This study provides readers with an intensive examination of the growing market for drugs and cosmetics for aging boomers.
Not only does the report focus on the demographics and behavior patterns of the baby boomer generation but it also examines the group's significance as a major market segment within the United States drug and cosmetics industries. From this analysis, BCC provides estimates for current and future trends in market size, market participants, product lines and consumer attitudes.
REASONS FOR DOING THIS STUDY
Dramatic changes are taking place as "baby boomers" approach "old age." Many boomers are now over 50 and if one expands the definition to include the "war-baby" cohort then many are retired and about to receive Social Security. This generation has not mimicked preceding generations but has been one of trendsetters. Its members have a high participation rate in sports activities and are very exercise oriented. Consequently, in addition to experiencing the problems associated with aging, they will experience many sports-related problems.
Also, the concept of "looking one's age" does not appeal to a large number of members of this demographic, both male and female, and their reliance on cosmetic products already has been demonstrated. It is BCC's goal to fully identify and examine these trends and to forecast future market changes through 2006.
CONTRIBUTIONS OF THE STUDY AND FOR WHOM
This study defines the major markets driven by "baby boomers" and provides detailed information on:
- drugs used to treat or prevent age-related disorders
- vitamins, nutritionals and herbals targeted to senior citizens
- hormone replacement therapy and other menopausal therapies
- prostate medications
- hair regrowth products
- impotency treatments
- skin care and antiwrinkle products
- sunscreen products.
This study will prove particularly beneficial to pharmaceutical and cosmetics industry participants who hold marketing, management and technical development positions. It also will benefit readers who are suppliers to these industries as well as investors, venture capitalists, and those interested in demographic trends within these industries.
SCOPE AND FORMAT
Included in this study are all products classified as drugs and cosmetics. These include products sold over-the-counter or by prescription. Also included are vitamins and herbal remedies, although these are not considered drugs.
These markets are defined in light of current and potential products, market segments, governmental and regulatory agencies, major companies competing in this market, relative market shares and impact of the worldwide market status.
METHODOLOGY AND INFORMATION SOURCES
The primary data collection method for this report focuses on interviews with industry and trade personnel, company sources, annual reports, government agency personnel, industry observers, scientists and industry professional organizations, as well as a survey of the retail markets. In addition to these primary data sources, secondary data research techniques included a literature search of BCC's extensive library, as well as medical and libraries.
All data were analyzed by BCC personnel to determine specific findings and to make forecasts. Once these forecasts were obtained, they were validated by consultation with industry experts. Consequently, all estimates provided in this report represent a consensus opinion of BCC personnel, industry participants and industry observers. Growth forecasts are made in constant 2001 dollars based on the U.S. manufacturers' (wholesale) price level unless otherwise noted.
Related Reports
Track the Latest Global Tariff Developments
In today's fast-paced global economy, tariffs are no longer static—they are dynamic levers shaped by geopolitical realignments, supply chain vulnerabilities, inflationary pressures, and sustainability-driven trade reforms. As governments worldwide recalibrate their trade strategies, businesses are left to navigate a maze of shifting rules, rising costs, and regulatory uncertainty.
Our analysis empowers you with real-time updates and in-depth expert analysis on all facets of global tariff activity. From new trade agreements and sanctions to abrupt tariff hikes and retaliatory duties, we monitor developments across borders, sectors, and industries—so you don't have to.
Whether it's the ongoing U.S.–China trade dynamics, the evolving EU Carbon Border Adjustment Mechanism (CBAM), or the emerging policies in India, ASEAN, and Latin America, we provide full-spectrum coverage. We also track multilateral trade negotiations, World Trade Organization (WTO) rulings, and sector-specific duty structures—ensuring you are always ahead of global trade shifts.
With our analysis, you can stay informed, identify risks, and confidently respond to tariff changes—no matter where you operate.
Ready to see what tariff means for your business?
Consult with our experts or request your custom Tariff Impact Brife today
Stay Informed, Stay Competitive
In today's interconnected and unpredictable global economy, staying ahead of tariff shifts is not just important—it's essential. BCC Research provides decision-makers with trusted, research-driven insights that turn uncertainty into opportunity.
Our in-depth market analysis and trade intelligence help you decode how tariff changes impact your specific sector—manufacturing, healthcare, technology, agriculture, or energy. We break down complex data into actionable knowledge through comprehensive reports, expert commentaries, and sector-focused forecasts.
Our analysis includes:
- Thorough breakdowns of current and proposed tariff policies and how they affect regional and global trade flows.
- Sector-specific implications, helping you understand the strategic impact on sourcing, pricing, and competitiveness.
- Forward-looking insights to support risk management, planning, and response strategies for evolving trade conditions.
With BCC Research, you gain more than just information—you gain clarity and confidence to make well-informed decisions in a volatile trade environment.
Don't let tariffs catch you off guard—let our insights guide your strategy.
Recent Reports
Lung Cancer Therapeutics: Global Markets
The global market for lung cancer therapeutics is expected to grow from $32.5 billion in 2025 and is projected to reach $49.5 billion by the end of 2030, at a compound annual growth rate (CAGR) of 8.8% during the forecast period of 2025 to 2030.
Global Bispecific Antibodies Market
This report provides an overview of the global bispecific antibodies market and analyzes market trends. It includes global revenue ($ million) for the base year data for 2022- 2024 and estimated data for the forecast period from 2025 through 2030.
Neuroprotective Agents: Therapeutic Applications and Global Markets
The global market for neuroprotective agents is expected to grow from $43.9 billion in 2025 and is projected to reach $60.9 billion by the end of 2030, at a compound annual growth rate (CAGR) of 6.7% during the forecast period of 2025 to 2030.
Radioligand Therapeutics in Cancer Treatment: Global Markets
The global market for radioligand therapeutics in cancer treatment is estimated to grow from $2.6 billion in 2025 to $4.8 billion by the end of 2030, at a compound annual growth rate (CAGR) of 13.1% from 2025 through 2030.
Monoclonal Antibodies for Oncology: Global Markets
The global market for monoclonal antibodies in oncology is expected to grow from $129.3 billion in 2025 and is projected to reach $228 billion by the end of 2030, at a compound annual growth rate (CAGR) of 12% during the forecast period of 2025 to 2030.
Top Trending Reports
Stem Cell and Regenerative Therapy: Global Markets
The global market for stem cell and regenerative therapy is projected to grow from an estimated $16.7 billion in 2025 to $43.8 billion by 2030, at a compound annual growth rate (CAGR) of 21.3% from 2025 to 2030.
Infusion Pumps and Devices: Technologies and Global Markets
The global market for infusion pumps and devices is expected to grow from $9.7 billion in 2025 and is projected to reach $14.2 billion by the end of 2030, at a compound annual growth rate (CAGR) of 7.9% during the forecast period of 2025 to 2030.
Validation, Calibration, and Standardization in the Life Sciences Market
The global market for validation, calibration, and standardization in life sciences was valued at $2.8 billion in 2025 and is estimated to reach $3.9 billion by 2030, at a compound annual growth rate (CAGR) of 6.7% from 2025 through 2030.
Noninvasive Cancer Diagnostics: Technologies and Global Markets
The global market for noninvasive cancer diagnostic technologies is expected to grow from $119.9 billion in 2025 and is projected to reach $165.2 billion by the end of 2030, at a compound annual growth rate (CAGR) of 6.6% during the forecast period of 2025 to 2030.
Neuroprotective Agents: Therapeutic Applications and Global Markets
The global market for neuroprotective agents is expected to grow from $43.9 billion in 2025 and is projected to reach $60.9 billion by the end of 2030, at a compound annual growth rate (CAGR) of 6.7% during the forecast period of 2025 to 2030.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More